The Emerging Role of Chemotherapy in Metastatic Prostate Cancer

home / insights / chemotherapy-in-metastatic-prostate-cancer
The Use of Taxanes Earlier in Prostate Cancer

EP. 1: The Use of Taxanes Earlier in Prostate Cancer

Daniel Petrylak, MD, Yale School of Medicine;Nicholas Vogelzang, MD, Comprehensive Cancer Center
March 18th 2020
Sequencing Therapy in Castrate-Resistant Prostate Cancer

EP. 2: Sequencing Therapy in Castrate-Resistant Prostate Cancer

Daniel Petrylak, MD, Yale School of Medicine;Nicholas Vogelzang, MD, Comprehensive Cancer Center
March 18th 2020
Repeat Molecular Testing in Advanced Prostate Cancer

EP. 3: Repeat Molecular Testing in Advanced Prostate Cancer

Daniel Petrylak, MD, Yale School of Medicine;Nicholas Vogelzang, MD, Comprehensive Cancer Center
March 18th 2020
Impact of the CARD Trial for Treating Metastatic CRPC

EP. 4: Impact of the CARD Trial for Treating Metastatic CRPC

Daniel Petrylak, MD, Yale School of Medicine;Nicholas Vogelzang, MD, Comprehensive Cancer Center
March 18th 2020
PARP Inhibitors in Castrate-Resistant Prostate Cancer

EP. 5: PARP Inhibitors in Castrate-Resistant Prostate Cancer

Daniel Petrylak, MD, Yale School of Medicine;Nicholas Vogelzang, MD, Comprehensive Cancer Center
March 18th 2020
Checkpoint Inhibitor Therapy in Prostate Cancer

EP. 6: Checkpoint Inhibitor Therapy in Prostate Cancer

Daniel Petrylak, MD, Yale School of Medicine;Nicholas Vogelzang, MD, Comprehensive Cancer Center
March 18th 2020
Using Taxanes Frontline in Metastatic Prostate Cancer

EP. 7: Using Taxanes Frontline in Metastatic Prostate Cancer

Daniel Petrylak, MD, Yale School of Medicine;Nicholas Vogelzang, MD, Comprehensive Cancer Center
March 18th 2020
Cabazitaxel for the Treatment of mCRPC

EP. 8: Cabazitaxel for the Treatment of mCRPC

Daniel Petrylak, MD, Yale School of Medicine;Nicholas Vogelzang, MD, Comprehensive Cancer Center
March 18th 2020
CARD Trial In Metastatic CRPC

EP. 9: CARD Trial In Metastatic CRPC

Daniel Petrylak, MD, Yale School of Medicine;Nicholas Vogelzang, MD, Comprehensive Cancer Center
March 18th 2020
Counseling Patients With mCRPC

EP. 10: Counseling Patients With mCRPC

Daniel Petrylak, MD, Yale School of Medicine;Nicholas Vogelzang, MD, Comprehensive Cancer Center
March 18th 2020
Management of mCRPC During COVID-19

EP. 11: Management of mCRPC During COVID-19

Daniel Petrylak, MD, Yale School of Medicine;Nicholas Vogelzang, MD, Comprehensive Cancer Center
March 18th 2020
mCRPC: Advice for Treatment During COVID-19

EP. 12: mCRPC: Advice for Treatment During COVID-19

Daniel Petrylak, MD, Yale School of Medicine;Nicholas Vogelzang, MD, Comprehensive Cancer Center
March 18th 2020